High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,573,682
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Horich William Todd
• Officer • SVP, Commercial Operations
Discretionary Sell
2026-03-10
$244,145
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Commercial Operations
Discretionary Sell
|
2026-03-10 | $244,145 | S | Form 4 |
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Horich William Todd
• Officer • SVP, Commercial Operations
Discretionary SellΔOwn -50.0%
2026-03-09
$239,652
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Commercial Operations
Discretionary SellΔOwn -50.0%
|
2026-03-09 | $239,652 | S | Form 4 |
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
Mottola Frank
• Officer • SVP, Chief Tech. Ops. Officer
Discretionary Sell
2026-03-09
$87,074
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Officer • SVP, Chief Tech. Ops. Officer
Discretionary Sell
|
2026-03-09 | $87,074 | S | Form 4 |
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
GEMAYEL GEORGES
• Director
Discretionary SellΔOwn -24.4%
2026-03-06
$465,711
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -24.4%
|
2026-03-06 | $465,711 | S | Form 4 |
|
SUPN
S
SUPERNUS PHARMACEUTICALS, INC.
GEMAYEL GEORGES
• Director
Discretionary SellΔOwn -26.2%
2026-03-05
$537,100
|
||||||
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -26.2%
|
2026-03-05 | $537,100 | S | Form 4 |